SCHEMBL6510261

SCHEMBL6510261

Cc1nc(NC(N)=NCc2ccc(-c3ccccc3)cc2)nc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 6/20 0.52
SMN1; SMN2 Q16637 4/20 0.52
ALDH1A1 P00352 4/20 0.52
HPGD P15428 1/20 0.52
KMT2A Q03164 5/20 0.51
MEN1 O00255 4/20 0.51
NPC1 O15118 3/20 0.51
RAB9A P51151 3/20 0.51
MAPT P10636 3/20 0.51
ALOX12 P18054 2/20 0.49
SIGMAR1 Q99720 2/20 0.47
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
STAT3 P40763 1/20 0.45
RECQL P46063 1/20 0.45
HIF1A Q16665 1/20 0.45
ATP4A P20648 6/20 0.44
ATP4B P51164 6/20 0.44
MPO P05164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6507782 0.86 LMNA (0.48) LMNASMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL6508538 0.83 RAB9A (0.74) LMNASMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL6518559 0.81 SMN1; SMN2 (0.55) LMNASMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL6507985 0.80 NPC1 (0.47) SMN1; SMN2KMT2AMEN1NPC1RAB9A
SCHEMBL6511310 0.76 KMT2A (0.54) LMNASMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL17897822 0.76 LMNA (0.58) LMNASMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL5923425 0.76 CTNNB1 (0.43) LMNASMN1; SMN2ALDH1A1HPGDKMT2A
SCHEMBL6509589 0.73 RAB9A (0.63) LMNASMN1; SMN2ALDH1A1KMT2AMEN1
SCHEMBL6510332 0.72 KMT2A (0.55) SMN1; SMN2ALDH1A1KMT2AMEN1NPC1
SCHEMBL31457433 0.72 SMN1; SMN2 (0.54) LMNASMN1; SMN2ALDH1A1HPGDKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005095345-A2 HETEROARYL GUANIDINES AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-10-13 WO claimed